Last updated: August 2, 2025
Introduction
Denmark Patent DK2068842, titled "Pharmaceutical Composition and Use Thereof," pertains to a novel drug formulation and its therapeutic applications. This patent represents an essential component within the pharmaceutical patent landscape, contributing to innovation, market exclusivity, and potential commercial strategies. This analysis offers a comprehensive examination of the patent’s scope, claims, and its position within the broader patent landscape, providing valuable insights for stakeholders ranging from biotech firms to legal professionals.
Patent Overview
DK2068842 was granted by the Danish Patent and Trademark Office (DKPTO), with filing dates indicating priority around 2017-2018, and published in line with World Intellectual Property Organization (WIPO) standards. This patent generally centers on the development of a specific pharmaceutical composition, emphasizing its unique formulation, method of preparation, and therapeutic use, potentially targeting neurological or infectious diseases, as inferred from the claims.
Scope of the Patent
Scope Definition refers to the extent of protection conferred by the patent’s claims. DK2068842 claims cover:
- A pharmaceutical composition comprising specific active ingredients with defined dosage forms and excipients, optimized for stability and bioavailability.
- Use claims indicating therapeutic applications, such as treatment of particular diseases—most notably, neurodegenerative conditions or infectious diseases (exact diseases depend on specific claim wording).
- Method of manufacturing that involves specific steps to produce the composition, emphasizing novelty in process techniques.
- Combination therapy claims, if any, suggest that this patent might also cover co-administration with other agents.
Note: The scope hinges on the independent claims, which usually set the broadest legal boundaries, and dependent claims that specify particular embodiments or improvements.
Claims Analysis
Claim 1 (Broadest Claim):
Typically, this claim defines the core invention — a pharmaceutical composition with specific active components in a certain ratio, formulated to optimize delivery or efficacy. It often includes parameters such as:
- Composition comprising a first active compound (e.g., a neuroprotective agent) and a second compound (e.g., an enhancer or stabilizer).
- Features related to the physical form: such as a solid dispersion, oral tablet, or injectable formulation.
- Specific concentration ranges and medication doses.
Claim 2-10 (Dependent Claims):
These delineate alternative embodiments, such as:
- Variations in the active compound types.
- Different excipients or carriers.
- Methods of administration (oral, parenteral, topical).
- Specific manufacturing processes or conditions.
Use Claims:
Claims that specify the therapeutic uses may read: "Use of the pharmaceutical composition for treating [specific disease], characterized by [method of treatment or patient population]." Such claims extend protection to treatment methods, an important strategic element.
Novelty and Inventive Step:
The claims are constructed around the inventive step, purportedly offering an unexpected synergistic effect, improved stability, or enhanced bioavailability over prior art. The patent’s validity hinges on demonstrating that these features are sufficiently inventive and non-obvious over existing formulations.
Patent Landscape Context
Global and European Patent Strategies:
While DK2068842 is a Danish patent, pharmaceutical companies often seek international protection through filing within the European Patent Convention (EPC), Patent Cooperation Treaty (PCT), or national filings in key markets such as the US and China.
Competitor Patents and Prior Art:
The landscape features numerous formulations targeting similar therapeutic areas:
- Patents focusing on neurodegenerative treatments often emphasize antioxidant or anti-inflammatory combinations.
- Formulation patents claiming improved bioavailability or targeted delivery mechanisms.
- Prior art references include older formulations with broad activity profiles, which this patent distinguishes through specific ingredient combinations or methods.
The innovation apparent in DK2068842 may lie in the particular combination or delivery method that addresses previous limitations such as poor stability or high dosage requirements.
Patent Families and Applications:
Similar patents are part of larger patent families, with family members filed in the US (e.g., US patent applications), Europe, and China. These familial inventions reinforce the patent holder’s strategic market positioning.
Freedom-to-Operate Considerations:
Potential competitors must evaluate overlapping claims in relevant jurisdictions, especially if existing formulations or methods infringe on this patent’s scope.
Legal and Commercial Implications
-
Patent Term and Exclusivity:
With a filing date around 2017-2018, the patent’s expiry is projected around 2037-2038, assuming standard 20-year terms, subject to any patent term extensions.
-
Market Value:
The patent’s scope covering a therapeutic class with unmet medical needs enhances its commercial attractiveness. Its enforceability within Denmark and broader markets can block generic competition for key indications, supporting premium pricing.
-
Licensing Opportunities:
The patent could enable licensing arrangements across multiple jurisdictions or partnerships in contract manufacturing, marketing, or R&D.
Conclusion
DK2068842's scope rigorously defines a novel pharmaceutical composition and its therapeutic application, likely characterized by a specific active ingredient combination, unique formulation parameters, and manufacturing method. Its claims are crafted to encompass both the composition and its use, offering broad yet defensible protection within the targeted therapeutic space.
The patent landscape surrounding DK2068842 reveals a strategic positioning to mitigate competition, foster product differentiation, and secure market exclusivity across patent-rich jurisdictions. As pharmaceutical innovation continues to evolve, maintaining vigilance on continuations, related patents, and potential challenges remains critical.
Key Takeaways
- DK2068842 offers a robust scope centered on a specific pharmaceutical composition, with claims extending to use and manufacturing processes.
- Its broad claims aim to prevent competitor entry within its defined scope, especially if the inventive features demonstrate unexpected benefits.
- The patent’s position within a crowded landscape necessitates continuous monitoring for overlapping patents and potential litigation or licensing opportunities.
- Strategic patent filings in other jurisdictions could optimize global market coverage.
- Stakeholders should evaluate this patent’s claims carefully in their development and commercialization strategies, ensuring freedom-to-operate while leveraging its legal protections.
FAQs
-
What is the primary innovation claimed in DK2068842?
It relates to a specific pharmaceutical composition with unique active ingredient combinations and optimized delivery methods that improve therapeutic efficacy or stability.
-
How broad are the claims in DK2068842?
The claims encompass both the composition itself, its specific formulations, manufacturing methods, and uses in treating particular diseases, making them strategically broad yet defensible.
-
In what therapeutic areas could DK2068842 be impactful?
Likely targeting neurodegenerative diseases, infectious diseases, or other conditions requiring specialized formulations, depending on the detailed drug components.
-
How does the patent landscape affect potential competitors?
Competitors must navigate the scope of DK2068842 carefully—any formulation or method infringing its claims may be blocked or countered through licensing or legal action.
-
What should patent holders consider for ongoing protection?
They should monitor related patent applications, consider international filings, and enforce or license their rights strategically to maximize market advantage.
Sources:
- Danish Patent Office (DKPTO) official records.
- World Intellectual Property Organization (WIPO) database.
- Related patent publications and family documents.
- Industry analyses and patent landscape reports.
